429 results match your criteria: "Joint Research Center for Human Retrovirus Infection.[Affiliation]"

Background: Although Japan is a major endemic area for human T-lymphotropic virus type 1 (HTLV-1) and the virus has been well-studied in this region, there is limited research on HTLV-1 in surrounding regions. In this study, we determined the complete genome sequences of HTLV-1 strains isolated from Taiwan and Japan and investigated the geographic characteristics of molecular subgroups and substitution mutations to understand the spread of HTLV-1 and its correlation with human migration.

Methodology/principal Findings: The complete genome sequences of 26 HTLV-1 isolates from Taiwan were determined using next-generation sequencing and were compared with those of 211 isolates from Japan in terms of subgroup and genetic mutations.

View Article and Find Full Text PDF
Article Synopsis
  • - This study explores the effectiveness of antibody testing for assessing immunity and diagnosing conditions like multisystem inflammatory syndrome related to COVID-19, focusing on antibodies targeting the SARS-CoV-2 spike protein.
  • - Researchers measured the neutralizing activity of immunoglobulin-G (IgG) in COVID-19 convalescent patients, finding a strong correlation between serum neutralizing activity (IgG-EC) and specific antibodies (S-IgG).
  • - The findings suggest that quantitative S-IgG tests can reliably estimate neutralizing antibody activity, provided the cut-off values for interpreting results are carefully established for accuracy.
View Article and Find Full Text PDF

Two-step evolution of HIV-1 budding system leading to pandemic in the human population.

Cell Rep

February 2024

Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan; Graduate School of Medicine, the University of Tokyo, Tokyo 1130033, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 2778561, Japan; CREST, Japan Science and Technology Agency, Kawaguchi 3320012, Japan. Electronic address:

The pandemic HIV-1, HIV-1 group M, emerged from a single spillover event of its ancestral lentivirus from a chimpanzee. During human-to-human spread worldwide, HIV-1 diversified into multiple subtypes. Here, our interdisciplinary investigation mainly sheds light on the evolutionary scenario of the viral budding system of HIV-1 subtype C (HIV-1C), a most successfully spread subtype.

View Article and Find Full Text PDF

Unspliced HIV-1 RNAs function as messenger RNAs for Gag or Gag-Pol polyproteins and progeny genomes packaged into virus particles. Recently, it has been reported that fate of the RNAs might be primarily determined, depending on transcriptional initiation sites among three consecutive deoxyguanosine residues (GGG tract) downstream of TATA-box in the 5' long terminal repeat (LTR). Although HIV-1 RNA transcription starts mostly from the first deoxyguanosine of the GGG tract and often from the second or third deoxyguanosine, RNAs beginning with one guanosine (G1-form RNAs), whose transcription initiates from the third deoxyguanosine, were predominant in HIV-1 particles.

View Article and Find Full Text PDF

Virological characteristics of the SARS-CoV-2 BA.2.86 variant.

Cell Host Microbe

February 2024

Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. Electronic address:

Article Synopsis
  • In late 2023, the SARS-CoV-2 BA.2.86 variant emerged alongside the dominant XBB descendants like EG.5.1, distinguishing itself with over 30 mutations in its spike protein.
  • Modeling showed BA.2.86 has a higher reproduction number compared to EG.5.1, suggesting it spreads more easily.
  • Despite its increased spread, BA.2.86 demonstrated lower pathogenicity and replication capacity in hamsters, indicating it may be less severe, while remaining sensitive to four existing antiviral treatments.
View Article and Find Full Text PDF

Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2.

Int J Mol Sci

January 2024

Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 19 (COVID-19) and employs angiotensin-converting enzyme 2 (ACE2) as the receptor. Although the expression of ACE2 is crucial for cellular entry, we found that the interaction between ACE2 and the Spike (S) protein in the same cells led to its downregulation through degradation in the lysosomal compartment via the endocytic pathway. Interestingly, the ability of the S protein from previous variants of concern (VOCs) to downregulate ACE2 was variant-dependent and correlated with disease severity.

View Article and Find Full Text PDF

Identification of dihydroorotate dehydrogenase inhibitor, vidofludimus, as a potent and novel inhibitor for influenza virus.

J Med Virol

January 2024

Division of Biological Information Technology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.

Influenza A virus (IAV) infection causes respiratory disease. Recently, infection of IAV H5N1 among mammals are reported in farmed mink. Therefore, to discover antivirals against IAV, we screened a compound library by using the RNA-dependent RNA polymerase (RdRp) assay system derived from H5N1 IAV including a drug-resistant PA mutant (I38T) and a viral polymerase activity enhancing PB2 mutant (T271A).

View Article and Find Full Text PDF

Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution.

Lancet Microbe

April 2024

Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, Japan. Electronic address:

View Article and Find Full Text PDF

Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals.

Lancet Infect Dis

March 2024

Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, Japan. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • The centrosome plays a crucial role in organizing microtubules and forming the mitotic spindle during cell division, with abnormal proliferation linked to cancer.
  • Research indicates that primary cells, specifically primary mouse embryonic fibroblasts (MEF), are more informative for studying early carcinogenesis than immortalized cells, which often have genetic changes.
  • Experiments showed that the PARP inhibitor 3-aminobenzamide induced centrosome amplification in immortalized MEF, while a stronger inhibitor was needed for primary MEF, and neither resulted in chromosomal aneuploidy, highlighting the complexity of genetic changes required for cancer development.
View Article and Find Full Text PDF
Article Synopsis
  • The gut microbiota is crucial for the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment, leading to interest in using specific bacteria to improve outcomes.
  • A specific strain of bacteria, MIYAIRI 588 (CBM588), has been shown to improve overall survival in lung cancer patients undergoing chemoimmunotherapy, especially in those with low PD-L1 expression.
  • CBM588 appears to enhance the benefits of chemoimmunotherapy even in patients taking proton pump inhibitors or antibiotics, suggesting its potential for further study in combination with immunotherapy.
View Article and Find Full Text PDF

Adult T-cell leukemia/lymphoma (ATL) is triggered by infection with human T-cell lymphotropic virus-1 (HTLV-1). Here, we describe the reprogramming of pyrimidine biosynthesis in both normal T cells and ATL cells through regulation of uridine-cytidine kinase 2 (UCK2), which supports vigorous proliferation. UCK2 catalyzes the monophosphorylation of cytidine/uridine and their analogues during pyrimidine biosynthesis and drug metabolism.

View Article and Find Full Text PDF

Virological characteristics of the SARS-CoV-2 JN.1 variant.

Lancet Infect Dis

February 2024

Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, Japan. Electronic address:

View Article and Find Full Text PDF

Amebiasis, which is caused by (), is the second leading cause of parasite-related death worldwide. It manifests from asymptomatic carriers to severe clinical conditions, like colitis and liver abscesses. Amebiasis is commonly seen in developing countries, where water and food are easily contaminated by feces because of the poor sanitation.

View Article and Find Full Text PDF

Idiotopes of antibodies against HIV-1 CD4-induced epitope shared with those against microorganisms.

Immunology

April 2024

Division of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.

Induction of antibodies (Abs) against the conformational CD4-induced (CD4i) epitope is frequent in HIV-1 infection. However, the mechanism of development of anti-CD4i Abs is unclear. We used anti-idiotypic (aID) monoclonal Abs (mAbs) of anti-CD4i mAbs to isolate anti-CD4i mAbs from infected subjects and track the causative antigens.

View Article and Find Full Text PDF

Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells.

Int J Mol Sci

November 2023

Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga 849-8501, Japan.

Acute myeloid leukemia (AML) is a heterogenous myeloid neoplasm that remains challenging to treat. Because intensive conventional chemotherapy reduces survival rates in elderly patients, drugs with lower toxicity and fewer side effects are needed urgently. 2-Hydroxypropyl-β-cyclodextrin (HP-β-CyD) is used clinically as a pharmaceutical excipient for poorly water-soluble drugs.

View Article and Find Full Text PDF

Osteosarcoma is rare but is the most common bone tumor. Diagnostic tools such as magnetic resonance imaging development of chemotherapeutic agents have increased the survival rate in osteosarcoma patients, although 5-year survival has plateaued at 70%. Thus, development of new treatment approaches is needed.

View Article and Find Full Text PDF
Article Synopsis
  • Convalescent plasma therapy involves using plasma from recovered COVID-19 patients to treat those with severe cases of the disease.
  • A study with 59 participants investigated the safety and efficacy of this therapy, focusing on patients needing ventilation or those who died within two weeks of treatment.
  • Preliminary findings suggest that convalescent plasma therapy may be a viable treatment option for COVID-19, and the study aims to support its future use in severe cases.
View Article and Find Full Text PDF
Article Synopsis
  • The World Health Organization estimates that 5-10 million people are infected with HTLV-1, but this number could be low due to limited data.
  • Reliable data exists for only about 1.5 billion people worldwide, leaving many infections potentially undetected.
  • The study evaluates a new rapid test, Espline HTLV-I/II, which could enhance our ability to quickly and easily identify HTLV-1 infections without needing expensive lab equipment.
View Article and Find Full Text PDF

Sinus macrophages in draining lymph nodes (DLNs) are involved in anti-tumor immune reactions. CD169 (Sialoadhesin, Siglec-1) is expressed on sinus macrophages and is considered a surrogate marker for the immunostimulatory phenotype of macrophages. In this study, the significance of sinus macrophages in immunotherapy was evaluated using mouse models.

View Article and Find Full Text PDF

Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review.

Biomolecules

October 2023

Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-8556, Japan.

Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL). HTLV-1 carriers have a lifelong asymptomatic balance between infected cells and host antiviral immunity; however, 5-10% of carriers lose this balance and develop ATL. Coinfection with promotes ATL development, suggesting that the immunological status of infected individuals is a determinant of HTLV-1 pathogenicity.

View Article and Find Full Text PDF

Epitope-dependent effect of long-term cART on maintenance and recovery of HIV-1-specific CD8 T cells.

J Virol

November 2023

Division of International Collaboration Research and Tokyo Joint Laboratory, Department of Frontier Research, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.

HIV-1-specific CD8 T cells are anticipated to become effector cells for curative treatment using the "shock and kill" approach in people living with HIV-1 (PLWH) under combined antiretroviral therapy (cART). Previous studies demonstrated that the frequency of HIV-1-specific CD8 T cells is reduced under cART and their functional ability remains impaired. These studies analyzed T-cell responses to a small number of HIV-1 epitopes or overlapping HIV-1 peptides.

View Article and Find Full Text PDF

HIV-1 protective epitope-specific CD8 T cells in HIV-1-exposed seronegative individuals.

iScience

November 2023

Tokyo Laboratory and Division of International Collaboration Research, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 162-0052, Japan.

Although previous studies have reported HIV-1-specific T cell responses in HIV-1-exposed seronegative (HESN) individuals, there has been no detailed analysis of these T cells against HIV-1 infection. We investigated HIV-1-specific CD8 T cell responses in 200 Japanese HESN men who have sex with men (MSM). T cell responses to 143 well-characterized HIV-1 epitope peptides were analyzed by intracellular cytokine staining assay consisting of 3-week cultures of PBMCs stimulated with peptides.

View Article and Find Full Text PDF

During the replication of viral genomes, RNA viruses produce double-stranded RNA (dsRNA), through the activity of their RNA-dependent RNA polymerases (RdRps) as viral replication intermediates. Recognition of viral dsRNA by host pattern recognition receptors - such as retinoic acid-induced gene-I (RIG-I)-like receptors and Toll-like receptor 3 - triggers the production of interferon (IFN)-β via the activation of IFN regulatory factor (IRF)-3. It has been proposed that, during the replication of viral genomes, each of RIG-I and melanoma differentiation-associated gene 5 (MDA5) form homodimers for the efficient activation of a downstream signalling pathway in host cells.

View Article and Find Full Text PDF

Hepatitis B is a viral hepatitis, which is caused by infection of hepatitis B virus (HBV). This disease progresses to chronic hepatitis, cirrhosis and liver cancer. To treat hepatitis B, exclusion of virus and covalently closed circular DNA (cccDNA) that is formed in hepatocyte nucleus is necessary.

View Article and Find Full Text PDF